The Bush administration announced Thursday it had finalized new rules to speed the availability of generic drugs by making it more difficult for drug patent-holders to use the legal system to impede a generic drug's release.
Low doses of a generic blood-thinning drug can prevent the recurring, dangerous blood clots that afflict about 750,000 Americans annually, researchers announced Monday on the New England Journal of Medicine's Web site.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.